Home › Funds › Cormorant Asset Management, LP › GRTX
Cormorant Asset Management, LP position in GRTX
ELECTRA THERAPEUTICS INC
Cormorant Asset Management, LP reported holding 3,365,533 shares of GRTX (ELECTRA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$37.9M, representing 2.71% of its reported portfolio and ranking #11 among its reported holdings. Cormorant Asset Management, LP first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Cormorant Asset Management, LP's GRTX position evolved
Cormorant Asset Management, LP first disclosed a stake in GRTX in Q3 2026 at 3,365,533 shares (US$37.9M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 3.37M | $37.86M | New |
About GRTX and 13F data
GRTX (ELECTRA THERAPEUTICS INC) is a company whose sector is not yet classified in our data. 57 other funds we track also report a position in GRTX — the largest reported positions include ORBIMED ADVISORS LLC (US$77.5M), Redmile Group, LLC (US$61.1M), EQT Fund Management S.a r.l. (US$42.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GRTX
- ORBIMED ADVISORS LLC 6.89M sh · $77.46M · Q3 2026
- Redmile Group, LLC 5.43M sh · $61.10M · Q3 2026
- EQT Fund Management S.a r.l. 3.80M sh · $42.70M · Q3 2026
- Nextech Invest Ltd. 2.64M sh · $29.66M · Q3 2026
- Blue Owl Capital Holdings LP 2.61M sh · $29.38M · Q3 2026
- Sanofi 2.46M sh · $27.70M · Q3 2026
- MIC Capital Management UK LLP 1.98M sh · $22.24M · Q3 2026
- EcoR1 Capital, LLC 1.70M sh · $19.12M · Q3 2026
- Logos Global Management LP 1.00M sh · $11.25M · Q3 2026
- Boxer Capital Management, LLC 450.00K sh · $5.06M · Q3 2026
- Monashee Investment Management LLC 100.00K sh · $1.12M · Q3 2026
More on Cormorant Asset Management, LP
FAQ
How long has Cormorant Asset Management, LP held GRTX?
Cormorant Asset Management, LP has disclosed GRTX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Cormorant Asset Management, LP's current position in GRTX?
As of Q3 2026, Cormorant Asset Management, LP holds 3.37M shares of GRTX (ELECTRA THERAPEUTICS INC), valued at $37.86M, representing 2.71% of its reported portfolio and ranking #11.
Has Cormorant Asset Management, LP been buying or selling GRTX?
In the latest 13F filing (Q3 2026), Cormorant Asset Management, LP newly opened its position in GRTX.
Which other funds hold GRTX?
Other major institutional holders of GRTX include ORBIMED ADVISORS LLC, Redmile Group, LLC, EQT Fund Management S.a r.l., among 57 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.